MabVax Therapeutics – “Insights on MabVax’s HuMab 5B1 from the World Molecular Imaging Conference”

NEW YORK, NY / ACCESSWIRE / December 2, 2015 / MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) today published a new blog post on The Chairman’s Blog, written by the Company’s President and Chief Executive Officer, David Hansen. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

The Company’s HuMab 5B1 antibody was featured in five separate presentations at the World Molecular Imaging Congress (WMIC) in September. In his blog Mr. Hansen expanded on key points presented by the investigators from the Department of Radiology at Memorial Sloan Kettering Cancer Center (MSK) describing the novel use of HuMab 5B1 as both a PET imaging agent and a radioimmunotherapy agent targeting pancreatic cancer. “These experiments showed the remarkable utility of this antibody and what it can potentially become,” wrote Hansen. Read the full blog post from David Hansen on TheChairmansBlog.com (http://www.thechairmansblog.com/mabvax-therapeutics-inc/david-hansen/insights-on-mabvaxs-humab-5b1-from-the-world-molecular-imaging-conference/).

About MabVax

MabVax Therapeutics Holdings, Inc. is a clinical-stage biotechnology company focused on the development of vaccine and antibody-based products and vaccines to address unmet medical needs in the treatment of cancer. MabVax has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers with the Company’s proprietary vaccines. MabVax also has the exclusive license to the therapeutic vaccines from Memorial Sloan Kettering Cancer Center. MabVax has two cancer vaccines targeting recurrent sarcoma and ovarian cancer in proof-of-concept Phase II multicenter clinical trials, and a vaccine targeting neuroblastoma that will be ready for a Phase II clinical trial in 2016. Additional information is available at www.mabvax.com.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 434246